Recombinant antibodies and fragments recognising ganglioside N-glycolyl-gm3 and use thereof in the diagnosis and treatment of tumours

Details for Australian Patent Application No. 2004232391 (hide)

Owner Centro De Inmunologia Molecular

Inventors Talavera Perez, Ariel; Mateo De Acosta Del Rio, Cristina Maria; Roque Navarro, Loudes Tatiana; Moreno Frias, Ernesto; Rojas Dorantes, Gertrudis; Rodriguez Gonzalez, Mabel

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004232391

PCT Pub. Number WO2004/094477

Priority 2003-0092 23.04.03 CU

Filing date 22 April 2004

Wipo publication date 4 November 2004

Acceptance publication date 30 October 2008

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

15 December 2005 PCT application entered the National Phase

  PCT publication WO2004/094477 Priority application(s): WO2004/094477

30 October 2008 Application Accepted

  Published as AU-B-2004232391

26 February 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004232392-(Purin-6-yl) amino acid and production method thereof

2004232379-Conveyor belt transfer device